ProText Mobility Inc (TXTM)

[29YEARINVESTOR]

Yep! Bring the Action! The Green Rush is On and we Own it!
As in Green Tea and soon to be Green Cannabis!

TXTM encourages its investors and shareholders to connect and engage with them through social media. You can find us on the following;

YouTube: http://bit.ly/ProtextYouTube

Twitter: https://twitter.com/protxtm

Instagram: https://www.instagram.com/protextm/

1) F. Thielecke M Boschmann/Phytochemistry (2009) "The potential role of green tea catechins in the prevention of the metabolic syndrome"

2) Green tea and type 2 diabetes -- Integrated Medicine 3 (2014) 4-10;

3) World Health Organization -- Diabetes country profiles, 2016

About Protext Mobility, Inc.

Protext Mobility is engaged in the research and clinical testing of "bioceutical" products -- all natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions. The Company has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare® catechin complex, which was developed by Plandaí Biotechnology, Inc. Phytofare® is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare® Catechin Complex, has been clinically shown to have 10 times greater bioavailability over generic catechin extracts. What this means is that Phytofare® can deliver a therapeutic level of catechins, which function as powerful antioxidants, to the system where they remain active for over 24 hours. Plandaí grows the raw materials on its 7,500 acre Senteeko green tea estate in South Africa, where it produces the proprietary Phytofare® extracts in-house, allowing the Company a continuity of supply as well as quality control throughout the entire process. Targeted applications for the Company's products include arthritis, inflammation, anti-viral, and diabetes-related metabolic syndromes.

Please visit http://www.protextm.co for further information.

http://www.marketwatch.com/story/protext-mobility-discusses-potential-effectiveness-of-phytofare-green-tea-extract-in-treating-type-ii-diabetes-2017-03-07